![](/img/cover-not-exists.png)
FRI0426 Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up.
Kneepkens, E. L., Wei, J. C., Nurmohamed, M. T., Chen, C. Y., Yeo, K. J., van der Horst-Bruinsma, I. E., Wolbink, G. J., Krieckaert, C. L.Volume:
72
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2013-eular.1553
Date:
June, 2013
File:
PDF, 498 KB
english, 2013